Geriatric Medicines Market Report By Therapeutic Category (Analgesic, Anti-Hypertensive, Anti-Diabetic, Anticoagulant, Anti-Depressant), By Condition (Cardiovascular Ailments, Arthritis, Diabetes, Neurological Disorders, Cancer), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) & Regional Forecast 2021-2031

Oct 2021| FMR793B| Fact Market Research

Report Highlights

Geriatric Medicines Market- Scope of Report

A recent study by Fact.MR on the geriatric medicines market offers a 10-year forecast for 2021 to 2031. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering geriatric medicines.

The study also provides the dynamics responsible for influencing the future status of the geriatric medicines market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the geriatric medicines market, along with their product portfolios, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of geriatric medicines across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of geriatric medicines during the forecast period. Price point comparison by region with global average price is also considered in the study.

Key Questions Answered in Report

  • Which are the most lucrative geriatric medicines markets?
  • Which factors will impact the growth of geriatric medicines?
  • How will changing trends impact the strategies of market players?
  • How can market players capture the low-hanging opportunities across regions?
  • Which companies are leading the geriatric medicines industry?
  • What are the winning strategies of stakeholders in the market?

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of volume (‘000 Units) and value (US$ Mn).

Estimates at global and regional levels for geriatric medicines are available in terms of “US$ Mn” for value and in “‘000 Units” for volume. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report.

Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global geriatric medicines market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the geriatric medicines market during the forecast period.

Country-specific valuation on demand for geriatric medicines has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

In-depth Analysis on Competition Analysis

The report sheds light on leading manufacturers of geriatric medicines, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering geriatric medicines has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the geriatric medicines domain. 

Research Methodology

In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the geriatric medicines industry, and reach conclusions on the future growth parameters. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the drawn conclusions.

Secondary resources referred to by analysts during the preparation of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of the research report as a primary resource.

  • Table 1 : Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Therapeutic Category, 2016–2020
  • Table 2 : Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Therapeutic Category, 2021–2031
  • Table 3 : Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Analgesic, 2016–2020
  • Table 4 : Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Analgesic, 2021–2031
  • Table 5 : Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Antihypertensive, 2016–2020
  • Table 6 : Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Antihypertensive, 2021–2031
  • Table 7 : Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Statins, 2016–2020
  • Table 8 : Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Statins, 2021–2031
  • Table 9 : Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Antidiabetic, 2016–2020
  • Table 10 : Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Antidiabetic, 2021–2031
  • Table 11 : Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Proton Pump Inhibitor, 2016–2020
  • Table 12 : Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Proton Pump Inhibitor, 2021–2031
  • Table 13 : Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Anticoagulant, 2016–2020
  • Table 14 : Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Anticoagulant, 2021–2031
  • Table 15 : Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Antipsychotic and Antidepressant, 2016–2020
  • Table 16 : Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Antipsychotic and Antidepressant, 2021–2031
  • Table 17 : Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Others, 2016–2020
  • Table 18 : Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Others, 2021–2031
  • Table 19 : Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Condition, 2016–2020
  • Table 20 : Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Condition, 2021–2031
  • Table 21 : Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Cardiovascular, 2016–2020
  • Table 22 : Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Cardiovascular, 2021–2031
  • Table 23 : Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Arthritis, 2016–2020
  • Table 24 : Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Arthritis, 2021–2031
  • Table 25 : Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Diabetes, 2016–2020
  • Table 26 : Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Diabetes, 2021–2031
  • Table 27 : Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Neurological, 2016–2020
  • Table 28 : Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Neurological, 2021–2031
  • Table 29 : Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Cancer, 2016–2020
  • Table 30 : Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Cancer, 2021–2031
  • Table 31 : Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Osteoporosis, 2016–2020
  • Table 32 : Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Osteoporosis, 2021–2031
  • Table 33 : Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Respiratory, 2016–2020
  • Table 34 : Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Respiratory, 2021–2031
  • Table 35 : Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Distribution Channel, 2016–2020
  • Table 36 : Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Distribution Channel, 2021–2031
  • Table 37 : Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Hospital Pharmacies, 2016–2020
  • Table 38 : Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Hospital Pharmacies, 2021–2031
  • Table 39 : Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Retail Pharmacies, 2016–2020
  • Table 40 : Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Retail Pharmacies, 2021–2031
  • Table 41 : Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Online Pharmacies, 2016–2020
  • Table 42 : Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Online Pharmacies, 2021–2031
  • Table 43 : Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Region, 2016–2020
  • Table 44 : Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Region, 2021–2031
  • Table 45 : North America Geriatric Medicines Market Size (US$ Mn) Analysis, by Therapeutic Category, 2016–2020
  • Table 46 : North America Geriatric Medicines Market Size (US$ Mn) Forecast, by Therapeutic Category, 2021–2031
  • Table 47 : North America Geriatric Medicines Market Size (US$ Mn) Analysis, by Condition, 2016–2020
  • Table 48 : North America Geriatric Medicines Market Size (US$ Mn) Forecast, by Condition, 2021–2031
  • Table 49 : North America Geriatric Medicines Market Size (US$ Mn) Analysis, by Country, 2016–2020
  • Table 50 : North America Geriatric Medicines Market Size (US$ Mn) Forecast, by Country, 2021–2031
  • Table 51 : Europe Geriatric Medicines Market Size (US$ Mn) Analysis, by Therapeutic Category, 2016–2020
  • Table 52 : Europe Geriatric Medicines Market Size (US$ Mn) Forecast, by Therapeutic Category, 2021–2031
  • Table 53 : Europe Geriatric Medicines Market Size (US$ Mn) Analysis, by Condition, 2016–2020
  • Table 54 : Europe Geriatric Medicines Market Size (US$ Mn) Forecast, by Condition, 2021–2031
  • Table 55 : Europe Geriatric Medicines Market Size (US$ Mn) Analysis, by Country, 2016–2020
  • Table 56 : Europe Geriatric Medicines Market Size (US$ Mn) Forecast, by Country, 2021–2031
  • Table 57 : Asia Pacific Geriatric Medicines Market Size (US$ Mn) Analysis, by Therapeutic Category, 2016–2020
  • Table 58 : Asia Pacific Geriatric Medicines Market Size (US$ Mn) Forecast, by Therapeutic Category, 2021–2031
  • Table 59 : Asia Pacific Geriatric Medicines Market Size (US$ Mn) Analysis, by Condition, 2016–2020
  • Table 60 : Asia Pacific Geriatric Medicines Market Size (US$ Mn) Forecast, by Condition, 2021–2031
  • Table 61 : Asia Pacific Geriatric Medicines Market Size (US$ Mn) Analysis, by Country, 2016–2020
  • Table 62 : Asia Pacific Geriatric Medicines Market Size (US$ Mn) Forecast, by Country, 2021–2031
  • Table 63 : Latin America Geriatric Medicines Market Size (US$ Mn) Analysis, by Therapeutic Category, 2016–2020
  • Table 64 : Latin America Geriatric Medicines Market Size (US$ Mn) Forecast, by Therapeutic Category, 2021–2031
  • Table 65 : Latin America Geriatric Medicines Market Size (US$ Mn) Analysis, by Condition, 2016–2020
  • Table 66 : Latin America Geriatric Medicines Market Size (US$ Mn) Forecast, by Condition, 2021–2031
  • Table 67 : Latin America Geriatric Medicines Market Size (US$ Mn) Analysis, by Country, 2016–2020
  • Table 68 : Latin America Geriatric Medicines Market Size (US$ Mn) Forecast, by Country, 2021–2031
  • Table 69 : MEA Geriatric Medicines Market Size (US$ Mn) Analysis, by Therapeutic Category, 2016–2020
  • Table 70 : MEA Geriatric Medicines Market Size (US$ Mn) Forecast, by Therapeutic Category, 2021–2031
  • Table 71 : MEA Geriatric Medicines Market Size (US$ Mn) Analysis, by Condition, 2016–2020
  • Table 72 : MEA Geriatric Medicines Market Size (US$ Mn) Forecast, by Condition, 2021–2031
  • Table 73 : MEA Geriatric Medicines Market Size (US$ Mn) Analysis, by Country, 2016–2020
  • Table 74 : MEA Geriatric Medicines Market Size (US$ Mn) Forecast, by Country, 2021–2031
  • Table 75 : U.S. Geriatric Medicines Market Size (US$ Mn), 2021-2031
  • Table 76 : Canada Geriatric Medicines Market Size (US$ Mn), 2021-2031
  • Table 77 : Brazil Geriatric Medicines Market Size (US$ Mn), 2021-2031
  • Table 78 : Mexico Geriatric Medicines Market Size (US$ Mn), 2021-2031
  • Table 79 : Argentina Geriatric Medicines Market Size (US$ Mn), 2021-2031
  • Table 80 : Germany Geriatric Medicines Market Size (US$ Mn), 2021-2031
  • Table 81 : France Geriatric Medicines Market Size (US$ Mn), 2021-2031
  • Table 82 : Italy Geriatric Medicines Market Size (US$ Mn), 2021-2031
  • Table 83 : Spain Geriatric Medicines Market Size (US$ Mn), 2021-2031
  • Table 84 : U.K. Geriatric Medicines Market Size (US$ Mn), 2021-2031
  • Table 85 : Benelux Geriatric Medicines Market Size (US$ Mn), 2021-2031
  • Table 86 : Russia Geriatric Medicines Market Size (US$ Mn), 2021-2031
  • Table 87 : China Geriatric Medicines Market Size (US$ Mn), 2021-2031
  • Table 88 : Japan Geriatric Medicines Market Size (US$ Mn), 2021-2031
  • Table 89 : South Korea Geriatric Medicines Market Size (US$ Mn), 2021-2031
  • Table 90 : India Geriatric Medicines Market Size (US$ Mn), 2021-2031
  • Table 91 : Thailand Geriatric Medicines Market Size (US$ Mn), 2021-2031
  • Table 92 : Indonesia Geriatric Medicines Market Size (US$ Mn), 2021-2031
  • Table 93 : Malaysia Geriatric Medicines Market Size (US$ Mn), 2021-2031
  • Table 94 : Australia & New Zealand Geriatric Medicines Market Size (US$ Mn), 2021-2031
  • Table 95 : GCC Countries Geriatric Medicines Market Size (US$ Mn), 2021-2031
  • Table 96 : Egypt Geriatric Medicines Market Size (US$ Mn), 2021-2031
  • Table 97 : South Africa Geriatric Medicines Market Size (US$ Mn), 2021-2031
  • Table 98 : Turkey Geriatric Medicines Market Size (US$ Mn), 2021-2031
  • Figure 1 : Global Mechanical Ventilators Market Snapshot
  • Figure 2 : Global Mechanical Ventilators Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2021–2031
  • Figure 3 : Market Value Share By Product Type (2020)
  • Figure 4 : Market Value Share By Interface (2020)
  • Figure 5 : Market Value Share By End User (2020)
  • Figure 6 : Market Value Share By Region (2020)
  • Figure 7 : Global Mechanical Ventilators Market Value Share, by Product Type, 2021 and 2031
  • Figure 8 : Global Mechanical Ventilators Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021–2031, by Critical Care Ventilators
  • Figure 9 : Global Mechanical Ventilators Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021–2031, by Neonatal Ventilators
  • Figure 10 : Global Mechanical Ventilators Market Value Share, by Interface, 2021 and 2031
  • Figure 11 : Global Mechanical Ventilators Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021–2031, by Invasive Ventilators
  • Figure 12 : Global Mechanical Ventilators Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021–2031, by Noninvasive Ventilators
  • Figure 13 : Global Mechanical Ventilators Market Value Share, by End-user, 2021 and 2031
  • Figure 14 : Global Mechanical Ventilators Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals and Clinics, 2021–2031
  • Figure 15 : Global Mechanical Ventilators Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Ambulatory Surgery Centres, 2021–2031
  • Figure 16 : Global Mechanical Ventilators Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Gynecology Clinics, 2021–2031
  • Figure 17 : Global Mechanical Ventilators Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2021–2031
  • Figure 18 : Global Mechanical Ventilators Market Value Share, by Region, 2021 and 2031
  • Figure 19 : North America Mechanical Ventilators Market Value (US$ Mn) Forecast, 2021–2031
  • Figure 20 : North America Market Attractiveness Analysis, by Country
  • Figure 21 : North America Mechanical Ventilators Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 22 : North America Mechanical Ventilators Market Value Share Analysis, by Interface, 2021 and 2031
  • Figure 23 : North America Mechanical Ventilators Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 24 : North America Mechanical Ventilators Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 25 : Europe Mechanical Ventilators Market Value (US$ Mn) Forecast, 2021–2031
  • Figure 26 : Europe Market Attractiveness Analysis, by Country
  • Figure 27 : Europe Mechanical Ventilators Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 28 : Europe Mechanical Ventilators Market Value Share Analysis, by Interface, 2021 and 2031
  • Figure 29 : Europe Mechanical Ventilators Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 30 : Europe Mechanical Ventilators Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 31 : Asia Pacific Mechanical Ventilators Market Value (US$ Mn) Forecast, 2021–2031
  • Figure 32 : Asia Pacific Market Attractiveness Analysis, by Country/Sub-region
  • Figure 33 : Asia Pacific Mechanical Ventilators Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 34 : Asia Pacific Mechanical Ventilators Market Value Share Analysis, by Interface, 2021 and 2031
  • Figure 35 : Asia Pacific Mechanical Ventilators Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 36 : Asia Pacific Mechanical Ventilators Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 37 : Latin America Mechanical Ventilators Market Value (US$ Mn) Forecast, 2021–2031
  • Figure 38 : Latin America Market Attractiveness Analysis, by Country
  • Figure 39 : Latin America Mechanical Ventilators Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 40 : Latin America Mechanical Ventilators Market Value Share Analysis, by Interface, 2021 and 2031
  • Figure 41 : Latin America Mechanical Ventilators Market Value Share Analysis, by End User, 2021 and 2031
  • Figure 42 : Latin America Mechanical Ventilators Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 43 : Middle East & Africa Mechanical Ventilators Market Value (US$ Mn) Forecast, 2021–2031
  • Figure 44 : Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region
  • Figure 45 : Middle East & Africa Mechanical Ventilators Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 46 : Middle East & Africa Mechanical Ventilators Market Value Share Analysis, by Interface, 2021 and 2031
  • Figure 47 : Middle East & Africa Mechanical Ventilators Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 48 : Middle East & Africa Mechanical Ventilators Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 49 : Teleflex Incorporated Revenue (US$ Bn) and Y-o-Y Growth (%), 2016–2020
  • Figure 50 : Teleflex Incorporated R&D Expense (%), 2016–2020
  • Figure 51 : Teleflex Incorporated Breakdown of Net Sales, by Region, 2020
  • Figure 52 : Teleflex Incorporated Breakdown of Net Sales, by End Market, 2020
  • Figure 53 : Dragerwerk AG & Co. KGaA Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2020
  • Figure 54 : Dragerwerk AG & Co. KGaA Breakdown of Net Sales, by Region, 2020
  • Figure 55 : Dragerwerk AG & Co. KGaA Marketing & Sales and R&D Expenses, 2016–2020
  • Figure 56 : GE Healthcare Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2020
  • Figure 57 : GE Healthcare Breakdown of Net Sales, by Region, 2020
  • Figure 58 : GE Healthcare Breakdown of Net Sales, by Product Segment, 2020
  • Figure 59 : Medtronic plc Revenue (US$ Bn) and Y-o-Y Growth (%), 2016–2020
  • Figure 60 : Medtronic plc Marketing & Sales and R&D Expenses, 2016–2020
  • Figure 61 : Medtronic plc Breakdown of Net Sales, by Business Segment, 2020
  • Figure 62 : Medtronic plc Breakdown of Net Sales, by Region, 2020
  • Figure 63 : Koninklijke Philips N.V. Breakdown of Net Sales, by Region, 2020
  • Figure 64 : Merck & Co., Inc. Break-up of Net Sales, by Region, 2020
  • Figure 65 : AstraZeneca Revenue (US$ Bn) and Y-o-Y Growth (%), 2016–2020
  • Figure 66 : AstraZeneca Breakdown of Net Sales, by Region, 2020
  • Figure 67 : AstraZeneca Marketing & Sales and R&D Expenses, 2016–2020
  • Figure 68 : Bristol-Myers Squibb Company Revenue (US$ Bn) and Y-o-Y Growth (%), 2016–2020
  • Figure 69 : Bristol-Myers Squibb Company R&D Intensity (%) - Company Level or Segment Level, 2016–2020
  • Figure 70 : Bristol-Myers Squibb Company Breakdown of Net Sales, by Region, 2020
  • Figure 71 : Novartis AG Revenue (US$ Bn) and Y-o-Y Growth (%), 2016–2020
  • Figure 72 : Novartis AG Marketing & Sales and R&D Expenses, 2016–2020
  • Figure 73 : Novartis AG Breakdown of Net Sales, by Business Segment, 2020
  • Figure 74 : Novartis AG Breakdown of Net Sales, by Region, 2020
  • Figure 75 : Sanofi S.A. Breakdown of Net Sales, by Region, 2020
  • Figure 76 : Sanofi S.A. Revenue (US$ Bn) and Y-o-Y Growth (%), 2016–2020
  • Figure 77 : Sanofi S.A. Breakdown of Net Sales, by Business Segment, 2020
  • Figure 78 : Sanofi S.A. R&D Intensity and Sales & Marketing Intensity (Pharmaceutical Segment) - Company Level, 2016–2020
  • Figure 79 : GlaxoSmithKline plc Revenue (US$ Bn) and Y-o-Y Growth (%), 2016–2020
  • Figure 80 : GlaxoSmithKline plc Marketing & Sales and R&D Expenses, 2016–2020
  • Figure 81 : GlaxoSmithKline plc Breakdown of Net Sales, by Business Segment, 2020
  • Figure 82 : GlaxoSmithKline plc Breakdown of Net Sales, by Region, 2020
  • Figure 83 : Eli Lilly and Company Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2020
  • Figure 84 : Eli Lilly and Company R&D Intensity (%) - Company Level or Segment Level, 2016–2020
  • Figure 85 : Eli Lilly and Company Breakdown of Net Sales, by Region, 2020
  • Figure 86 : Abbott Laboratories, Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2020
  • Figure 87 : Abbott Laboratories, Breakdown of Net Sales, by Business Segment, 2020
  • Figure 88 : Abbott Laboratories, Breakdown of Net Sales, by Region 2020
  • Figure 89 : Boehringer Ingelheim GmbH, Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2020
  • Figure 90 : Boehringer Ingelheim GmbH, Breakdown of Net Sales, by Business Segment, 2020
  • Figure 91 : Boehringer Ingelheim GmbH, Breakdown of Net Sales, by Region 2020
  • Figure 92 : Boehringer Ingelheim GmbH, R&D (US$ Mn) and Y-o-Y Growth (%), 2016–2020

Fact.MR is an independent, pure play market intelligence firm incorporated with an objective to deliver high quality, customized market research solutions that help our clients successfully go to the market equipped with actionable insights capable of impacting crucial business decisions.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS